Claudio Papi

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Mario Cottone, Anna Kohn, Marco Daperno et al. · Clinical Gastroenterology and Hepatology · 2010 · 354 citations

Inflammation, Advanced Age, Severe Infections +9

Colectomy rate in acute severe ulcerative colitis in the infliximab era

Annalisa Aratari, Claudio Papi, Valeria Clemente et al. · Digestive and Liver Disease · 2008 · 190 citations

Colectomy Rate, Gastroenterology, Visceral Surgery +5

Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial

Claudio Papi, A Ciaco, M. Koch et al. · Alimentary Pharmacology & Therapeutics · 1995 · 183 citations

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆

Ambrogio Orlando, Alessandro Armuzzi, Claudio Papi et al. · Digestive and Liver Disease · 2010 · 140 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +12

Early versus late surgery for ileo‐caecal Crohn’s disease

Annalisa Aratari, Claudio Papi, Gioacchino Leandro et al. · Alimentary Pharmacology & Therapeutics · 2007 · 108 citations · Full text